News Overview

Bajaj Holdings Investment will hold a meeting of the Board of Directors of the Company on 28 April 2022

Devyani International has allotted 1462500 equity shares under ESOS on 31 March 2022 Consequent to the allotment the paid-up share capital of the Company is increased from 1203273878 equity shares to 1204736378 equity shares having face value of Re 1 each

Bajaj Finance will hold a meeting of the Board of Directors of the Company on 26 April 2022

Hero MotoCrop sold 450154 units in March 2022 This is a sequential growth over the volume sales in the month of February when Hero MotoCorp dispatched 358254 units of motorcycles and scooters indicating a gradual recovery in the economy In FY22 the auto industry witnessed significant disruptions triggered by the second and third wave of Coronavirus pandemic restricting customer movement Hero MotoCorp sold 4944150 units […]

Chitradurga Spintex will hold a meeting of the Board of Directors of the Company on 6 April 2022

Power Grid Corporation of India POWERGRID has transferred balance 26Percentage equity shareholding of POWERGRID Vizag Transmission PVTL to PGlnvlT on 31 March 2022 at a consideration of Rs 33078 crore after adjustments of dividend received by POWERGRID from PVTL With this POWERGRID has Nil shareholding in PVTL; and POWERGRID has relinquished its right on additional revenue accruing to POWERGRID Parli Transmission POWERGRID Warora Transmission and […]

JSW Energy announced that its subsidiary JSW Neo Energy has entered into a Memorandum of Understanding with the Government of Chhattisgarh for setting up 1000 MW capacity of Hydro Pumped Storage Project viz Hasdev Bango Pumped Storage Project in the State of Chhattisgarh JSW Energy through its green growth vehicle JSW Neo Energy has been expeditiously securing key resources for Hydro PSPs in various resource […]

Deccan Health Care will hold a meeting of the Board of Directors of the Company on 9 April 2022

Srestha Finvest will hold a meeting of the Board of Directors of the Company on 5 April 2022

Lupin has signed Definitive Agreement with Anglo-French Drugs Industries for acquiring a portfolio of brands including all rights and interests associated with such products to strengthen the Companys presence in Vitamins Minerals Supplements and CNS segments